U.S. Markets closed
  • S&P 500

    3,699.12
    +32.40 (+0.88%)
     
  • Dow 30

    30,218.26
    +248.74 (+0.83%)
     
  • Nasdaq

    12,464.23
    +87.05 (+0.70%)
     
  • Russell 2000

    1,892.45
    +43.75 (+2.37%)
     
  • Crude Oil

    46.09
    +0.45 (+0.99%)
     
  • Gold

    1,837.70
    +0.90 (+0.05%)
     
  • Silver

    24.32
    +0.18 (+0.76%)
     
  • EUR/USD

    1.2127
    -0.0022 (-0.1819%)
     
  • 10-Yr Bond

    0.9690
    +0.0490 (+5.33%)
     
  • Vix

    20.79
    -0.49 (-2.30%)
     
  • GBP/USD

    1.3438
    -0.0015 (-0.1088%)
     
  • USD/JPY

    104.1400
    +0.2800 (+0.2696%)
     
  • BTC-USD

    19,153.76
    +19,153.76 (+0.00%)
     
  • CMC Crypto 200

    365.19
    -14.05 (-3.71%)
     
  • FTSE 100

    6,550.23
    +59.96 (+0.92%)
     
  • Nikkei 225

    26,751.24
    -58.13 (-0.22%)
     

Weekly CEO Buys Highlight

GuruFocus.com

According to GuruFocus insider data, these are the largest CEO buys from the past week.

Athenex CEO bought 6,000 shares

Athenex Inc. (NASDAQ:ATNX) CEO, Chairman and 10% owner Johnson Yiu Nam Lau bought 6,000 shares on Oct. 16 at a price of $10.16. The price of the stock has increased by 0.69% since then.

dc38a0406a4be7c657e31704a00955d7.png
dc38a0406a4be7c657e31704a00955d7.png


The biopharmaceutical company is dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer. Its mission is to improve the lives of cancer patients by creating more effective, safer and tolerable treatments. The company has organized its business model into three segments: the oncology innovation platform, the commercial platform and global supply chain platform, with operations in both the U.S. and China. The company has a market cap of $790.71 million. Its shares traded at $10.23 as of Oct. 18.

Net loss for the three months ending June 30 was $32 million compared to a net loss of $36.9 million in the same period last year.

Lau also bought 5,000 shares on Sept. 23 at a price of $13.86 and 3,000 shares on Sept. 27 at a price of $12.85. Since then, the price of the stock has decreased by 20.39%.

Chief Financial Officer Randoll Sze bought 1,000 shares on Sept. 30 at a price of $12.62 and 1,000 shares on Oct. 17 at a price of $10.99. The price of the stock has decreased by 6.92% since then.

Perceptive Life Sciences Master Fund, which is a 10% owner of the stock, bought 67,222 shares on Oct. 16 at a price of $10.29. Since then, the price of the stock has decreased by 0.58%.

Hersha Hospitality CEO bought 3,571 shares

Hersha Hospitality Trust (NYSE:HT) CEO Jay H. Shah bought 3,571 shares on Oct. 14 at a price of $13.90. The price of the stock has decreased by 2.81% since.

0ab4106fe6c38b6bb91a017b954c64ca.png
0ab4106fe6c38b6bb91a017b954c64ca.png

Hersha Hospitality Trust is a U.S.-based real estate investment trust that invests primarily in upscale, mid-scale and extended-stay hotels in urban gateway markets. These markets include New York, Washington DC, Boston, Philadelphia, South Florida, Connecticut and select markets on the West Coast among others. Hersha owns its hotels and investments in joint ventures through its operating partnership, Hersha Hospitality Limited Partnership, in which Hersha serves as a general partner. The company operates through a single segment, which is investment in hotel properties. The company's revenue streams include Room revenue and Other revenue. Room revenue comprises the vast majority of the firm's total revenue. The company has a market cap of $530.54 million. Its shares traded at $13.51 as of Oct. 18.

Net income for the second quarter of 2019 was $5.56 million compared to $11.84 million for the prior-year quarter.

President and Chief Operating Officer Neil H. Shah bought 3,571 shares on Oct. 14 at a price of $13.9. The price of the stock has decreased by 2.81% since.

Director John Sabin bought 900 shares on Sept. 26 at a price of $15. The price of the stock has decreased by 9.93% since.

For the complete list of stocks bought by their company CEOs, go to CEO Buys.

Disclosure: I do not own stock in any of the companies mentioned in the article.

Read more here:



Not a Premium Member of GuruFocus? Sign up for a free 7-day trial her

This article first appeared on GuruFocus.